Baillie Gifford & Co’s Exscientia Plc American Depositary Shares EXAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,848,276
Closed -$18.8M 285
2024
Q3
$18.8M Sell
3,848,276
-549,342
-12% -$2.88M 0.01% 184
2024
Q2
$22.4M Sell
4,397,618
-176,787
-4% -$872K 0.02% 174
2024
Q1
$26.2M Sell
4,574,405
-116,075
-2% -$721K 0.02% 177
2023
Q4
$30.1M Sell
4,690,480
-178,330
-4% -$1.01M 0.02% 176
2023
Q3
$22M Sell
4,868,810
-212,358
-4% -$1.37M 0.02% 181
2023
Q2
$30.1M Sell
5,081,168
-160,912
-3% -$987K 0.03% 173
2023
Q1
$27.8M Buy
5,242,080
+323,785
+7% +$2.2M 0.03% 174
2022
Q4
$26.2M Buy
4,918,295
+39,359
+0.8% +$249K 0.03% 177
2022
Q3
$40.1M Buy
4,878,936
+6,895
+0.1% +$69.6K 0.04% 152
2022
Q2
$53.1M Buy
4,872,041
+856,706
+21% +$10.2M 0.05% 153
2022
Q1
$57.8M Sell
4,015,335
-29,757
-0.7% -$507K 0.04% 166
2021
Q4
$79.9M Buy
+4,045,092
New +$85M 0.04% 157

Other funds holding EXAI

Baillie Gifford & Co's EXAI Position: Q4 2024 in Review

Baillie Gifford & Co sold out of Exscientia Plc American Depositary Shares (EXAI) in Q4 2024, closing a stake of 3,848,276 shares — an estimated $18.8M sold.

Baillie Gifford & Co first reported a position in EXAI in Q4 2021 and held it in 12 quarters. The position peaked at $79.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds EXAI as of Q4 2024.

  • Baillie Gifford & Co reported no remaining Exscientia Plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Baillie Gifford & Co sold 3,848,276 Exscientia Plc American Depositary Shares shares in Q4 2024, an estimated $18.8M.
  • Baillie Gifford & Co first reported a position in Exscientia Plc American Depositary Shares in Q4 2021 and held it in 12 quarters.
  • Baillie Gifford & Co's Exscientia Plc American Depositary Shares position peaked at $79.9M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q4 2024.

Based on Baillie Gifford & Co's 13F filing for Q4 2024, filed 31 Jan 2025.